Staar Surgical Co. Stock
Price
Target price
€39.20
€39.20
-0.780%
-0.31
-0.780%
€49.33
16.05.24 / Tradegate
WKN: 870353 / Symbol: STAA / Name: STAAR Surgical / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Staar Surgical Co. Stock
Staar Surgical Co. shows a slight decrease today, losing -€0.310 (-0.780%) compared to yesterday.
We see a rather positive sentiment for Staar Surgical Co. with 12 Buy predictions and 1 Sell predictions.
As a result the target price of 49 € shows a positive potential of 25.0% compared to the current price of 39.2 € for Staar Surgical Co..
Pros and Cons of Staar Surgical Co. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Staar Surgical Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | -0.780% | -1.779% | -10.009% | -33.060% | 35.033% | -60.436% | - |
| Orasure Tech | -2.450% | 2.575% | -1.646% | -3.629% | -35.839% | -37.841% | -39.608% |
| scPharmaceuticals | 6.700% | 3.241% | 6.699% | -55.176% | -22.435% | -7.083% | - |
| SI-BONE Inc | 0.730% | -3.497% | -2.128% | -42.500% | -27.368% | -45.669% | - |
Comments
STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Mizuho from $53.00 to $55.00. They now have a "buy" rating on the stock.
Show more
Ratings data for STAA provided by MarketBeat
STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Mizuho from $45.00 to $53.00. They now have a "buy" rating on the stock.
Show more
Ratings data for STAA provided by MarketBeat
STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Show more
Ratings data for STAA provided by MarketBeat
News
STAAR Surgical Reports First Quarter 2024 Results
STAAR Surgical Company (NASDAQ: K), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today
STAAR Surgical to Report First Quarter Results on May 7, 2024
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today